Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natrecor in Decompensated Heart Failure with Normal LVEF
NCT00505791Phase 4Withdrawn
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of nesiritide in heart failure with preserved ejection fraction (HFpEF), sponsored by University of Medicine and Dentistry of New Jersey. Planned start Aug 2007; status: withdrawn.
02
Drugs
nesiritide
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00505791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505791.